InvestorsHub Logo
Followers 210
Posts 10749
Boards Moderated 0
Alias Born 02/17/2007

Re: None

Tuesday, 12/14/2021 1:17:37 AM

Tuesday, December 14, 2021 1:17:37 AM

Post# of 6231
UBS has upgraded Pfizer (PFE +4.8%) to buy from hold due to several factors, including the revenue potential of the COVID-19 antiviral Paxlovid, its free cash flow, and its promising pipeline.
The firm has a $60 price target (~14% return based on Friday's close).
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PFE News